BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...a mezzanine funding.Lubman joined Werewolf in August 2020 after a stint as CBO of Impel NeuroPharma...
BioCentury | Aug 15, 2020
Management Tracks

Myriad chooses Diaz as new CEO; plus changes at Novocure, Werewolf, Jasper, Avacta, Tarsus and more

...Inc. hired Ellen Lubman as CBO, a new position. She held the same role at Impel NeuroPharma...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...A/S (CSE:NOVO B; NYSE:NVO) and currently serves as chairman of EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT). Impel NeuroPharma...
...Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. SutroVax Inc. Illumina Inc. Arrowhead Pharmaceuticals Inc. Tessa Therapeutics Pte. Ltd. Impel NeuroPharma...
BioCentury | Jan 11, 2020
Company News

Management Tracks: Wave CFO departs; plus Polaris, Turning Point, ADC, Relmada, Aravive, Affimed, Impel, Candel and more

...March 2020, to succeed Leila Alland. He was CMO at Molecular Partners AG (SIX:MOLN). Impel NeuroPharma...
...Kent Hawryluk president and CEO. Hawryluk co-founded and was CBO at Avidity Biosciences LLC. BioCentury Staff Impel NeuroPharma...
BioCentury | Oct 22, 2019
Emerging Company Profile

Intrepida: Tackling the innate immune system to treat cancer

...includes Indaco’s Elizabeth Robinson, Biouniversa CEO Giovanni Rizzo, Sofinnova’s David Kabakoff, Canaan’s Nina Kjellson, Impel NeuroPharma...
BioCentury | Apr 24, 2019
Financial News

Why Satsuma investors see room for another migraine therapy

...one other venture-backed company is developing an intranasal version of DHE for acute migraine. Impel NeuroPharma...
BioCentury | Dec 7, 2018
Financial News

Impel raises $67.5M series D

...Impel NeuroPharma Inc. (Seattle, Wash.) hopes to accelerate its clinical portfolio of intranasal CNS therapies with...
...Mittendorff and KKR's Ali Satvat will join Impel's board. Impel NeuroPharma Inc., Seattle, Wash. Mark Zipkin Impel NeuroPharma...
BioCentury | Dec 6, 2018
Financial News

Impel raises $67.5M series D

...Impel NeuroPharma Inc. (Seattle, Wash.) hopes to accelerate its clinical portfolio of intranasal CNS therapies with...
...disorder and schizophrenia. Norwest's Robert Mittendorff and KKR's Ali Satvat will join Impel's board. Mark Zipkin Impel NeuroPharma...
BioCentury | Nov 7, 2018
Company News

Management tracks: Myovant, Alkahest

...ophthalmology portfolio of the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). CNS disorder company Impel NeuroPharma...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...Henig as CMO. She was CMO at ProQR Therapeutics N.V. (NASDAQ:PRQR). Drug delivery company Impel NeuroPharma...
Items per page:
1 - 10 of 41
BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...a mezzanine funding.Lubman joined Werewolf in August 2020 after a stint as CBO of Impel NeuroPharma...
BioCentury | Aug 15, 2020
Management Tracks

Myriad chooses Diaz as new CEO; plus changes at Novocure, Werewolf, Jasper, Avacta, Tarsus and more

...Inc. hired Ellen Lubman as CBO, a new position. She held the same role at Impel NeuroPharma...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...A/S (CSE:NOVO B; NYSE:NVO) and currently serves as chairman of EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT). Impel NeuroPharma...
...Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. SutroVax Inc. Illumina Inc. Arrowhead Pharmaceuticals Inc. Tessa Therapeutics Pte. Ltd. Impel NeuroPharma...
BioCentury | Jan 11, 2020
Company News

Management Tracks: Wave CFO departs; plus Polaris, Turning Point, ADC, Relmada, Aravive, Affimed, Impel, Candel and more

...March 2020, to succeed Leila Alland. He was CMO at Molecular Partners AG (SIX:MOLN). Impel NeuroPharma...
...Kent Hawryluk president and CEO. Hawryluk co-founded and was CBO at Avidity Biosciences LLC. BioCentury Staff Impel NeuroPharma...
BioCentury | Oct 22, 2019
Emerging Company Profile

Intrepida: Tackling the innate immune system to treat cancer

...includes Indaco’s Elizabeth Robinson, Biouniversa CEO Giovanni Rizzo, Sofinnova’s David Kabakoff, Canaan’s Nina Kjellson, Impel NeuroPharma...
BioCentury | Apr 24, 2019
Financial News

Why Satsuma investors see room for another migraine therapy

...one other venture-backed company is developing an intranasal version of DHE for acute migraine. Impel NeuroPharma...
BioCentury | Dec 7, 2018
Financial News

Impel raises $67.5M series D

...Impel NeuroPharma Inc. (Seattle, Wash.) hopes to accelerate its clinical portfolio of intranasal CNS therapies with...
...Mittendorff and KKR's Ali Satvat will join Impel's board. Impel NeuroPharma Inc., Seattle, Wash. Mark Zipkin Impel NeuroPharma...
BioCentury | Dec 6, 2018
Financial News

Impel raises $67.5M series D

...Impel NeuroPharma Inc. (Seattle, Wash.) hopes to accelerate its clinical portfolio of intranasal CNS therapies with...
...disorder and schizophrenia. Norwest's Robert Mittendorff and KKR's Ali Satvat will join Impel's board. Mark Zipkin Impel NeuroPharma...
BioCentury | Nov 7, 2018
Company News

Management tracks: Myovant, Alkahest

...ophthalmology portfolio of the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). CNS disorder company Impel NeuroPharma...
BioCentury | Jul 16, 2018
Company News

Management tracks: Cerecor, Sangamo

...Henig as CMO. She was CMO at ProQR Therapeutics N.V. (NASDAQ:PRQR). Drug delivery company Impel NeuroPharma...
Items per page:
1 - 10 of 41